会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明授权
    • Succinoyl aminopyrazoles and related compounds
    • 琥珀酰氨基吡唑及相关化合物
    • US06974829B2
    • 2005-12-13
    • US10434528
    • 2003-05-07
    • Jay S. TungAshley C. GuinnEugene D. ThorsettMichael A. Pleiss
    • Jay S. TungAshley C. GuinnEugene D. ThorsettMichael A. Pleiss
    • C07D231/40C07D233/80C07D285/12C07D285/135A61K31/41A61P25/00C07P285/08
    • C07D285/135C07D231/40C07D233/80
    • This invention is directed to a class of compounds (Formula I) including succinoyl amino pyrazoles, succinoyl amino thiadiazoles, succinoyl amino acid esters, succinoyl amino acid amides, succinoyl amino alcohols, succinoyl amino ketones, succinoyl amino hydantoins, succinoyl anilines, and succinoyl derivatives of privileged structures. The invention is also directed to a pharmaceutical formation comprising such compound in a pharmaceutically acceptable salt form or prodrug thereof. The invention is further directed to a method for inhibiting β-amyloid peptide release and/or synthesis, a method for inhibiting γ-secretase activity and a method for treating neurological disorders associated with β-amyloid peptide production. The method comprises administering to a host a pharmaceutical formulation comprising an effective amount of a compound of Formula I. The compounds of Formula I are useful in the prevention and treatment of Alzheimer's disease.
    • 本发明涉及一类包括琥珀酰基氨基吡唑,琥珀酰基氨基噻二唑,琥珀酰氨基酸酯,琥珀酰氨基酰胺,琥珀酰氨基醇,琥珀酰氨基酮,琥珀酰基氨基乙内酰脲,琥珀酰基苯胺和琥珀酰基衍生物的化合物(式I) 的特权结构。 本发明还涉及药物组合物,其包含药学上可接受的盐形式的这种化合物或其前体药物。 本发明进一步涉及一种抑制β-淀粉样蛋白肽释放和/或合成的方法,一种抑制γ-分泌酶活性的方法和一种治疗与β-淀粉样蛋白肽生产相关的神经障碍的方法。 该方法包括向宿主施用包含有效量的式I化合物的药物制剂。式I化合物可用于预防和治疗阿尔茨海默氏病。